Forex
World
Market
Business
Cryptocurrency
Commodities
MAP
Publish for free
Business
financetom
/
Business
/
--The Marzetti Company Keeps Quarterly Dividend at $0.95 a Share, Payable Sept. 30 to Holders of Record Sept. 8
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
Forex
Stocks Market
Commodities
--The Marzetti Company Keeps Quarterly Dividend at $0.95 a Share, Payable Sept. 30 to Holders of Record Sept. 8
Aug 13, 2025 12:46 PM
03:21 PM EDT, 08/13/2025 (MT Newswires) --
Price: 183.22, Change: +2.47, Percent Change: +1.37
Previous page:
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Next page:
MBX Biosciences' Hypoparathyroidism Treatment a 'Key Catalyst,' Oppenheimer Says
Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Release time ⇩
Release time ⇧
Like count ⇩
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
MBX Biosciences' Hypoparathyroidism Treatment a 'Key Catalyst,' Oppenheimer Says
Jul 16, 2025
10:43 AM EDT, 07/16/2025 (MT Newswires) -- MBX Biosciences' ( MBX ) hypoparathyroidism drug, canvuparatide, is a key catalyst for the company as its potentially favorable efficacy to current treatments could be a $2 billion global peak sales opportunity, said Oppenheimer said in a Wednesday note. Oppenheimer said its enthusiasm for MBX Biosciences ( MBX ) stems from the company's...
Goldman Sachs' Results Top Views on Equity Trading, Investment Banking Gains
Jul 16, 2025
10:44 AM EDT, 07/16/2025 (MT Newswires) -- Goldman Sachs ( GS ) logged stronger-than-expected second-quarter results, buoyed by record equity trading revenue and a surge in investment banking gains. Per-share earnings rose to $10.91 from $8.62 a year earlier, above the FactSet-polled consensus estimate of $9.65. Revenue jumped 15% annually to $14.58 billion, while analysts projected $13.51 billion. At this...
Revelation Biosciences Completes Dosing for Phase 1b Trial of Gemini for Chronic Kidney Disease
Jul 16, 2025
10:41 AM EDT, 07/16/2025 (MT Newswires) -- Revelation Biosciences ( REVB ) said Wednesday it completed dosing for an escalating-dose phase 1b trial of intravenously-administered Gemini in people with stage 3 and 4 chronic kidney disease. The company said that, as planned, five groups were enrolled at three clinics in the US, and trial data sets are expected in Q3....
About
Terms and Conditions
Privacy policy
Cookie Settings
Contact Us
Services
Login
register
financetom
Market
Personal Finance
Business
Economy
Cryptocurrency
MAP
Links
zpostcode
Recruit
weather
mreligion
Yellowpages
sport
constellation
shopping
name
game
directory
literature
Word
tour
furnish
Lottery
tftnews
lyrics
News
digital
car
dir
Edu
Finance
Copyright 2023-2026 -
www.financetom.com
All Rights Reserved
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
MAP